Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 28, 2022; 28(28): 3608-3619
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3608
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3608
Figure 1 Differences in chemical classes and chemical structures of potassium-competitive acid blockers[12].
P-CAB: Potassium-competitive acid blocker.
Figure 2 Potassium-competitive acid blockers inhibit gastric H+/K+-ATPase by binding ionically to the enzyme and prevent further activation by the K+[7].
P-CAB: Potassium-competitive acid blocker.
- Citation: Leowattana W, Leowattana T. Potassium-competitive acid blockers and gastroesophageal reflux disease. World J Gastroenterol 2022; 28(28): 3608-3619
- URL: https://www.wjgnet.com/1007-9327/full/v28/i28/3608.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i28.3608